Latest News
Dicerna Pharmaceuticals signs contract with Novo Nordisk
20 November 2019 - United States-based Dicerna Pharmaceuticals has signed a contract with Denmark-based Novo Nordisk for discovering and developing drugs for liver-related cardio-metabolic diseases, it was reported yesterday.Both firms will make use ...
Genmab receives marketing authorisation in Europe for DARZALEX (Daratumumab) in combination with lenalidomide and dexamethasone in frontline multiple myeloma
20 November 2019 - Genmab A/S (CPH:GMAB), a biotechnology company specialising in the creation and development of differentiated antibody therapeutics for the treatment of cancer, announced on Tuesday the grant by the European Commission (EC) of mark...
Orphazyme announces receipt of Breakthrough Therapy Designation from US FDA for arimoclomol to treat Niemann-Pick Disease Type C
20 November 2019 - Biopharmaceutical company Orphazyme A/S (CPH:ORPHA.CO) announced on Tuesday the grant by the US Food and Drug Administration (FDA) of Breakthrough Therapy Designation for arimoclomol, an investigational drug for the treatment of Ni...
Moberg Pharma posts profit of SEK32.7m in Q1 2019
20 November 2019 - Moberg Pharma AB (STO:MOB) reported on Tuesday net profit after tax of SEK32.7m, or diluted EPS of SEK1.76, for the first quarter of 2019, from July 2019 to September 2019.This was an improvement over net profit after tax of SEK2.9...
Oncopeptides widens loss in Q3 2019
20 November 2019 - Oncopeptides AB (STO:ONCO) reported on Tuesday that it recorded a loss of SEK189.78m, or SEK3.53 per share, for the third quarter of 2019, from 1 July 2019 to 30 September 2019.This was a decline over loss of SEK94.05m, or SEK2.14 ...